Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Total 13F shares
-
17,394,292
-
Share change
-
+5,191,783
-
Total reported value
-
$408,238,068
-
Price per share
-
$23.49
-
Number of holders
-
48
-
Value change
-
+$121,776,022
-
Number of buys
-
35
-
Number of sells
-
10
Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q1 2022
As of 31 Mar 2022 Vera Therapeutics, Inc. - COMMON STOCK (VERA) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,394,292 shares of stock of the company.
Largest 10 holders included FMR LLC, Sofinnova Investments, Inc., Abingworth LLP, CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., Vivo Capital, LLC, VANGUARD GROUP INC, Octagon Capital Advisors LP, and Kynam Capital Management, LP.
This table shows 49 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.